Cancer Science · 2010 · 45 citations · 33 references
MedicineCancer BiologyOncologyCancer GeneticsMolecular OncologyOncogenesCancer BiomarkersCancer Cell SignalingCancer ProgressionOncogenic Signaling PathwaysSignal Transduction In CancerAcetylation PathwaysCancer Signaling PathwaysCell Growth RegulationLuciferase Reporter AssaysOncogenic TransformationSensitivityTherapeutic Resistance Mechanisms
Twist1 has been proposed to have oncogenic properties. Although Twist1 was reported to interact with p300/CBP-associated factor (PCAF) and to inhibit the functions of PCAF, it remains unclear how PCAF affects the functions of Twist1, cell growth, invasive ability, and cellular sensitivity to anticancer agents. We found that PCAF, Twist1, and Y-box binding protein-1 (YB-1) expressions were elevated in cisplatin- and doxorubicin-resistant cancer cells. Luciferase reporter assays revealed that PCAF manipulation modulated YB-1 transcription in a Twist1-dependent manner. In addition, PCAF regulated the Twist1 intracellular localization and the Twist1 transcriptional activity through its acetylation function to the Twist1. Suppression of PCAF expression reduced YB-1 expression in human urothelial cancer KK47 cells. As a result, the cell growth and invasive ability of KK47 cells was retarded by PCAF knockdown, and PCAF knockdown rendered KK47 cells sensitive to cisplatin and doxorubicin, but not to 5-fluorouracil. The present data suggest that Twist1 and YB-1 as well as PCAF may be promising molecular therapeutic targets.
33
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Jing Yang, Sendurai A. Mani, Joana Liu Donaher et al. · Cell · 2004 · 3.8K citations · Full text
CBP/p300 in cell growth, transformation, and development
Richard H. Goodman, Sarah M. Smolik · Genes & Development · 2000 · 1.8K citations · Full text
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Xiang‐Jiao Yang, Vasily Ogryzko, Jun‐ichi Nishikawa et al. · Nature · 1996 · 1.5K citations
DNA damage activates p53 through a phosphorylation–acetylation cascade
Kazuyasu Sakaguchi, Julio E. Herrera, Shinichi Saito et al. · Genes & Development · 1998 · 1.2K citations · Full text